Hubei Goto Biopharm Co.,Ltd. (300966.SZ) SHZ
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Hubei Goto Biopharm Co.,Ltd.
Sector
Healthcare
Industry
Biotechnology
Employees
893
First IPO Date
April 09, 2021
Key Executives
| Name | Title | Pay | Year Born |
| Zubin Xi | Chairman of the Board, GM, & Research and Development Director | 0 | 1970 |
| Wenjing Chen | Board Secretary & Deputy GM | 0 | 1973 |
| Minglei Li | Non Independent Director & Deputy GM | 0 | 1977 |
| Xiangdong Liu | Chief Financial Officer, Head of Accounting Agency & Non-Independent Director | 0 | 1974 |
Description
Hubei Goto Biopharm Co.,Ltd. is a Chinese enterprise specializing in the manufacture and distribution of active pharmaceutical ingredients (APIs) and intermediate compounds for steroid hormones. Its product line features essential starting materials such as 9a-hydroxy-4-androstenedione (9a-OHAD), bisnoralcohol (BA), sitolactone, 1,4-androstadienedione (ADD), and 4-androstenedione (4-AD). The company also provides a variety of intermediates, including those for estrogens, progesterone, non-steroidal substances, various other hormones, and corticosteroids. Furthermore, Hubei Goto Biopharm supplies additional raw materials for the pharmaceutical industry. The firm was established in Yicheng, China, in 2006.
